Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2014-02-10

Clinical Trial Update: Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK

View source ↗

Summary

An update on a UK study evaluating whether Pandemrix influenza vaccine is associated with an increased risk of solid organ transplant rejection; the trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pandemrix (influenza vaccine (split virion, inactivated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Influenza | Status: COMPLETED